Skip to main content
Caplight Logo









Resonant Therapeutics

Resonant Therapeutics

Private
Houston, TexasHealthcare & Life Scienceshttps://resonantrx.com/

Last Round

Grant

Sep 1, 2023

Total Funding Raised

$931,070

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Resonant Therapeutics is a biotechnology company that develops a drug discovery platform to identify novel tumor-selective targets and anti-tumor antibodies for cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

antibody discoveryoncology drug discoverybiotechtherapeutic antibodydrug discovery platformai-driven drug discoverytumor-selective targetshigh-throughput screeningbiopharma partnershipin silico drug discoverytherapeutic pipelinefunction-first discoverybiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Resonant Therapeutics Comparables

Compare Resonant Therapeutics with similar companies based on industry and business-model similarity.

Resonant Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kling Biotherapeutics
77%
Biolojic Design
76%
BigHat Biosciences
72%

Resonant Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2023
SeedOct 15, 2015

Resonant Therapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 24, 2026

    Monthly visitors grew 33% MoM.

  • Apr 1, 2026

    Monthly visitors grew 122% MoM.

Resonant Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Resonant Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Resonant Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Employee Range3
Year Founded2014
Last FundingSep 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?